$ARAT
Arax Holdings Corp

2023 Q3 Form 10-Q Financial Statement

#000175392623001252 Filed on September 22, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2022 Q3
Revenue $228.5K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit $228.5K
YoY Change
Gross Profit Margin 100.0%
Selling, General & Admin $379.3K $11.12K
YoY Change 3310.97% -24.46%
% of Gross Profit 165.98%
Research & Development $2.185M
YoY Change
% of Gross Profit 956.34%
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit 0.0%
Operating Expenses $2.565M $11.12K
YoY Change 22959.84% -24.44%
Operating Profit -$2.336M -$11.12K
YoY Change 20905.19% -24.44%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $334.7K
YoY Change
Pretax Income -$2.001M -$11.12K
YoY Change 17895.45% -24.44%
Income Tax
% Of Pretax Income
Net Earnings $810.00 -$11.12K
YoY Change -107.28% -24.44%
Net Earnings / Revenue 0.35%
Basic Earnings Per Share -$0.04 $0.00
Diluted Earnings Per Share -$0.01 -$1.076K
COMMON SHARES
Basic Shares Outstanding 51.30M shares 10.34M shares
Diluted Shares Outstanding 151.3M shares 10.34M shares

Balance Sheet

Concept 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $130.00
Short-Term Investments
Other Short-Term Assets $130.5K
YoY Change
Inventory
Prepaid Expenses
Receivables $680.7K
Other Receivables $0.00
Total Short-Term Assets $130.5K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $18.82M
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $19.50M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $130.5K
Total Long-Term Assets $19.50M
Total Assets $19.63M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $171.1K $23.62K
YoY Change 624.24% 60.48%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $228.8K $73.80K
YoY Change 210.09% 401.34%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $228.8K $73.80K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $228.8K $73.80K
YoY Change 210.09% 401.34%
SHAREHOLDERS EQUITY
Retained Earnings -$4.205M -$778.2K
YoY Change 440.33% 8.22%
Common Stock $117.6K $10.34K
YoY Change 1037.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $19.40M -$73.80K
YoY Change
Total Liabilities & Shareholders Equity $19.63M
YoY Change

Cashflow Statement

Concept 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income $810.00 -$11.12K
YoY Change -107.28% -24.44%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities -$2.437M $0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$268.0K
YoY Change
Cash From Investing Activities -$268.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.293M 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -2.437M 0.000
Cash From Investing Activities -268.0K
Cash From Financing Activities 2.293M 0.000
Net Change In Cash -412.4K 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$2.437M $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001566243
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-31
CY2022Q4 us-gaap Assets
Assets
usd
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
usd
CY2023Q3 arat Gain Or Loss
GainOrLoss
usd
CY2022Q4 arat Gain Or Loss
GainOrLoss
usd
CY2023Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
usd
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
usd
CY2023Q3 arat Related Party Notes
RelatedPartyNotes
usd
CY2022Q4 arat Related Party Notes
RelatedPartyNotes
usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
usd
CY2022Q3 us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations
usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-07-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-185928
dei Entity Registrant Name
EntityRegistrantName
ARAX HOLDINGS CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-0376721
dei Entity Address Address Line1
EntityAddressAddressLine1
820 E Park Ave
dei Entity Address Address Line2
EntityAddressAddressLine2
Bldg. D200
dei Entity Address City Or Town
EntityAddressCityOrTown
Tallahassee
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32301
dei City Area Code
CityAreaCode
564
dei Local Phone Number
LocalPhoneNumber
234-7009
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
117625624 shares
CY2023Q3 us-gaap Assets Current
AssetsCurrent
130518 usd
CY2023Q3 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
680658 usd
CY2023Q3 us-gaap Long Term Investments
LongTermInvestments
18818285 usd
CY2023Q3 us-gaap Assets
Assets
19629461 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
171080 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
116869 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
57756 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
57756 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
228835 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
174625 usd
CY2023Q3 us-gaap Liabilities
Liabilities
228835 usd
CY2022Q4 us-gaap Liabilities
Liabilities
174625 usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
10000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
10000 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
117570915 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
117570915 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10335294 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10335294 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
117570 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
10335 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23477806 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
684046 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4204751 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-879006 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
19400626 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-174625 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19629461 usd
CY2023Q3 us-gaap Revenues
Revenues
228518 usd
us-gaap Revenues
Revenues
682290 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
379295 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11122 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
831237 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
47785 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2185420 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3154142 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
2564715 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
11122 usd
us-gaap Operating Expenses
OperatingExpenses
3985379 usd
us-gaap Operating Expenses
OperatingExpenses
47785 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2336197 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11122 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3303089 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-47785 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
334743 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-750 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2001454 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11122 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3303839 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47785 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-2001454 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-11122 usd
us-gaap Profit Loss
ProfitLoss
-3303839 usd
us-gaap Profit Loss
ProfitLoss
-47785 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51295583 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151295583 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10335294 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
110335294 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51295583 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151295583 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10335294 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
110335294 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-174625 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-966939 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1141564 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
19732527 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
18590963 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
810 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
19400626 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3303839 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-47785 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-36663 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
680658 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
73363 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11122 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3911134 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
18818285 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18818285 usd
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
22785154 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
107236 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22892390 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations
162 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32453 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
130 usd
CY2023Q3 arat Working Capital Deficit
WorkingCapitalDeficit
19400626 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4204751 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84F_eus-gaap--UseOfEstimates_z2437LdfKTQ4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86E_zE7eiRjFqIW4">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amounts of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.</span></p>
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000000 shares
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
950000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
117570915 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
117570915 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10335294 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10335294 shares
CY2021Q1 arat Common Stock Issued For Loan And Compensation Expenses
CommonStockIssuedForLoanAndCompensationExpenses
100000 usd
CY2021Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
16166 usd
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
83834 usd
CY2023Q3 us-gaap Other Receivables
OtherReceivables
57757 usd
CY2022Q4 us-gaap Other Receivables
OtherReceivables
57757 usd

Files In Submission

Name View Source Status
0001753926-23-001252-index-headers.html Edgar Link pending
0001753926-23-001252-index.html Edgar Link pending
0001753926-23-001252.txt Edgar Link pending
0001753926-23-001252-xbrl.zip Edgar Link pending
arat-20230731.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g083729_10q.htm Edgar Link pending
g083729_ex31-1.htm Edgar Link pending
g083729_ex31-2.htm Edgar Link pending
g083729_ex32-1.htm Edgar Link pending
g083729_ex32-2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
arat-20230731_cal.xml Edgar Link unprocessable
arat-20230731_def.xml Edgar Link unprocessable
arat-20230731_lab.xml Edgar Link unprocessable
arat-20230731_pre.xml Edgar Link unprocessable
g083729_10q_htm.xml Edgar Link completed